Kenneth Bahrt, SVP, Chief Medical Officer at SAVIENT PHARMACEUTICALS INC (SVNT), bought 5,000 shares at $2.59 ($13K) on 2011-11-16, disclosed to the SEC on 2011-11-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| SVNT | SELL | 2013-10-17 | $6K | — | Filing → |
| SVNT | SELL | 2013-05-01 | $925 | — | Filing → |
| SVNT | SELL | 2013-02-06 | $30K | — | Filing → |